Insider Trading Alert - CSCO, IDXX And HTGC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 20, 2015, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $186.58 to $190,703,600.00.

Highlighted Stocks Traded by Insiders:

Cisco Systems (CSCO) - FREE Research Report

Johnson Kristina M, who is Director at Cisco Systems, sold 15,000 shares at $29.74 on May 20, 2015. Following this transaction, the Director owned 20,495 shares meaning that the stake was reduced by 42.26% with the 15,000-share transaction.

The shares most recently traded at $29.69, down $0.05, or 0.17% since the insider transaction. Historical insider transactions for Cisco Systems go as follows:

  • 4-Week # shares sold: 12,052
  • 12-Week # shares sold: 91,457
  • 24-Week # shares sold: 451,457

The average volume for Cisco Systems has been 26.2 million shares per day over the past 30 days. Cisco Systems has a market cap of $151.8 billion and is part of the technology sector and computer hardware industry. Shares are up 6.49% year-to-date as of the close of trading on Wednesday.

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP) based networking products and services related to the communications and information technology industry worldwide. The stock currently has a dividend yield of 2.82%. The company has a P/E ratio of 18.6. Currently, there are 19 analysts who rate Cisco Systems a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSCO - FREE

TheStreet Quant Ratings rates Cisco Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, reasonable valuation levels and increase in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cisco Systems Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

IDEXX Laboratories (IDXX) - FREE Research Report

End William T, who is Director at IDEXX Laboratories, sold 3,527 shares at $134.51 on May 20, 2015. Following this transaction, the Director owned 26,827 shares meaning that the stake was reduced by 11.62% with the 3,527-share transaction.

The shares most recently traded at $135.93, up $1.42, or 1.05% since the insider transaction. Historical insider transactions for IDEXX Laboratories go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 5,296
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 5,296

The average volume for IDEXX Laboratories has been 399,600 shares per day over the past 30 days. IDEXX Laboratories has a market cap of $6.3 billion and is part of the health care sector and drugs industry. Shares are down 7.51% year-to-date as of the close of trading on Wednesday.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company has a P/E ratio of 36.9. Currently, there are 5 analysts who rate IDEXX Laboratories a buy, 2 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IDXX - FREE

TheStreet Quant Ratings rates IDEXX Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, weak operating cash flow and relatively poor performance when compared with the S&P 500 during the past year. Get the full IDEXX Laboratories Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hercules Technology Growth Capital (HTGC) - FREE Research Report

Bluestein Scott, who is Chief Investment Officer at Hercules Technology Growth Capital, sold 6,000 shares at $12.65 on May 20, 2015. Following this transaction, the Chief Investment Officer owned 159,869 shares meaning that the stake was reduced by 3.62% with the 6,000-share transaction.

The shares most recently traded at $12.66, up $0.01, or 0.08% since the insider transaction. Historical insider transactions for Hercules Technology Growth Capital go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 3,127
  • 12-Week # shares sold: 16,000
  • 24-Week # shares bought: 3,127
  • 24-Week # shares sold: 135,132

The average volume for Hercules Technology Growth Capital has been 443,200 shares per day over the past 30 days. Hercules Technology Growth Capital has a market cap of $921.8 million and is part of the financial sector and real estate industry. Shares are down 15.32% year-to-date as of the close of trading on Wednesday.

Hercules Technology Growth Capital, Inc. The stock currently has a dividend yield of 9.76%. The company has a P/E ratio of 10.8. Currently, there are 4 analysts who rate Hercules Technology Growth Capital a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HTGC - FREE

TheStreet Quant Ratings rates Hercules Technology Growth Capital as a hold. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Hercules Technology Growth Capital Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers